A recent study in eClinicalMedicine assesses whether individuals with diabetes are more susceptible to developing long COVID, analyzing a UK cohort to explore the prolonged impact of SARS-CoV-2 infection in this population.
Following consultation with public health agencies and experts, the World Health Organization (WHO) publishes a global technical consultation report introducing updated terminology for pathogens that transmit through the air.
Study finds that receiving an annual COVID-19 vaccine is clinically and economically beneficial for individuals, regardless of insurance status, offering savings by reducing the likelihood of infection and its associated costs.
Large-scale study found that long COVID patients exhibit sustained inflammation and specific immune responses associated with varying symptoms, highlighting the importance of personalized treatment approaches.